- Home
- IKT vs IH Comparison
IKT vs IH Comparison
Compare IKT & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- IH
- Stock Information
- Founded
- IKT 2008
- IH 1996
- Country
- IKT United States
- IH China
- Employees
- IKT N/A
- IH N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- IKT Health Care
- IH Real Estate
- Exchange
- IKT Nasdaq
- IH Nasdaq
- Market Cap
- IKT 140.5M
- IH 146.3M
- IPO Year
- IKT 2020
- IH 2020
- Fundamental
- Price
- IKT $1.66
- IH $2.90
- Analyst Decision
- IKT Buy
- IH
- Analyst Count
- IKT 2
- IH 0
- Target Price
- IKT $8.00
- IH N/A
- AVG Volume (30 Days)
- IKT 97.5K
- IH 21.1K
- Earning Date
- IKT 08-14-2025
- IH 09-26-2025
- Dividend Yield
- IKT N/A
- IH 2.94%
- EPS Growth
- IKT N/A
- IH N/A
- EPS
- IKT N/A
- IH 0.26
- Revenue
- IKT N/A
- IH $123,701,096.00
- Revenue This Year
- IKT N/A
- IH $39.02
- Revenue Next Year
- IKT N/A
- IH N/A
- P/E Ratio
- IKT N/A
- IH $10.46
- Revenue Growth
- IKT N/A
- IH N/A
- 52 Week Low
- IKT $1.12
- IH $1.47
- 52 Week High
- IKT $4.20
- IH $3.60
- Technical
- Relative Strength Index (RSI)
- IKT 45.73
- IH 56.06
- Support Level
- IKT $1.66
- IH $2.52
- Resistance Level
- IKT $1.87
- IH $2.93
- Average True Range (ATR)
- IKT 0.10
- IH 0.20
- MACD
- IKT -0.01
- IH -0.00
- Stochastic Oscillator
- IKT 33.82
- IH 65.52
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.